Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Havekes, L. M.
Right arrow Articles by Klasen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Havekes, L. M.
Right arrow Articles by Klasen, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 28, 455-463, Copyright © 1987 by Lipid Research, Inc.


ARTICLES

A rapid micromethod for apolipoprotein E phenotyping directly in serum

LM Havekes, P de Knijff, U Beisiegel, J Havinga, M Smit and E Klasen

A new method for the apolipoprotein E phenotyping has been developed. The method is based on isoelectric focusing of either delipidated or guanidine-HC1-treated serum or plasma in a horizontal slab gel system followed by immunoblotting using either polyclonal or monoclonal anti- apolipoprotein E antibodies as first antibody. Apolipoprotein E phenotyping with this method in 200 serum samples that had been stored at -20 degrees C for more than one year gave exactly the same results as obtained with the conventional method based on isoelectric focusing of delipidated very low density lipoproteins isolated from fresh serum followed by protein staining. Compared with the conventional method, the present method is less laborious because ultracentrifugation to isolate VLDL is not needed; it is suitable for large scale screening purposes; it needs only a few microliters of serum or plasma, and can easily be performed with samples with low concentrations of apolipoprotein E.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Millar, C. Maugeais, K. Ikewaki, D. M. Kolansky, P.H. R. Barrett, E. C. Budreck, R. C. Boston, N. Tada, S. Mochizuki, J. C. Defesche, et al.
Complete Deficiency of the Low-Density Lipoprotein Receptor Is Associated With Increased Apolipoprotein B-100 Production
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 560 - 565.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. W. Stephens, M. M. Sozen, R. A. Whittall, M. J. Caslake, D. Bedford, J. Acharya, S. J. Hurel, and S. E. Humphries
Three Novel Mutations in the Apolipoprotein E Gene in a Sample of Individuals with Type 2 Diabetes Mellitus
Clin. Chem., January 1, 2005; 51(1): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. P. Simonen, H. K. Gylling, and T. A. Miettinen
Diabetes Contributes to Cholesterol Metabolism Regardless of Obesity
Diabetes Care, September 1, 2002; 25(9): 1511 - 1515.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M van Dam, M Zwart, F de Beer, A H M Smelt, M H Prins, M D Trip, L M Havekes, P J Lansberg, and J J P Kastelein
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia
Heart, September 1, 2002; 88(3): 234 - 238.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. G. Dik, C. Jonker, H. C. Comijs, L. M. Bouter, J. W.R. Twisk, G. J. van Kamp, and D. J.H. Deeg
Memory complaints and APOE-{epsilon}4 accelerate cognitive decline in cognitively normal elderly
Neurology, December 26, 2001; 57(12): 2217 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Rajaratnam, H. Gylling, and T. A. Miettinen
Cholesterol Absorption, Synthesis, and Fecal Output in Postmenopausal Women With and Without Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., October 1, 2001; 21(10): 1650 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
M. Shahmanesh, H. Jaleel, Y. DeSilva, J. D C Ross, M. Caslake, and R. Cramb
Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype
Sex Transm Inf, August 1, 2001; 77(4): 283 - 286.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Koch, N. Donarski, K. Goetze, M. Kreckel, H.-J. Stuerenburg, C. Buhmann, and U. Beisiegel
Characterization of four lipoprotein classes in human cerebrospinal fluid
J. Lipid Res., July 1, 2001; 42(7): 1143 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Relas, H. Gylling, and T. A. Miettinen
Fate of intravenously administered squalene and plant sterols in human subjects
J. Lipid Res., June 1, 2001; 42(6): 988 - 994.
[Abstract] [Full Text]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. Relas, H. Gylling, R. A. Rajaratnam, and T. A. Miettinen
Postprandial Retinyl Palmitate and Squalene Metabolism Is Age Dependent
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2000; 55(11): 515B - 521.
[Abstract] [Full Text]


Home page
StrokeHome page
M. G. Dik, D. J. H. Deeg, L. M. Bouter, E. H. Corder, A. Kok, and C. Jonker
Stroke and Apolipoprotein E {epsilon}4 Are Independent Risk Factors for Cognitive Decline : A Population-Based Study
Stroke, October 1, 2000; 31(10): 2431 - 2436.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. G. Dik, C. Jonker, L. M. Bouter, M. I. Geerlings, G. J. van Kamp, and D. J. H. Deeg
APOE-{epsilon}4 is associated with memory decline in cognitively impaired elderly
Neurology, April 11, 2000; 54(7): 1492 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. J. Packard, T. Demant, J. P. Stewart, D. Bedford, M. J. Caslake, G. Schwertfeger, A. Bedynek, J. Shepherd, and D. Seidel
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
J. Lipid Res., February 1, 2000; 41(2): 305 - 318.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. F. Vuorio, H. Gylling, H. Turtola, K. Kontula, P. Ketonen, and T. A. Miettinen
Stanol Ester Margarine Alone and With Simvastatin Lowers Serum Cholesterol in Families With Familial Hypercholesterolemia Caused by the FH-North Karelia Mutation
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. J. G. Sijbrands, M. J. V. Hoffer, A. E. Meinders, L. M. Havekes, R. R. Frants, A. H. M. Smelt, and P. De Knijff
Severe Hyperlipidemia in Apolipoprotein E2 Homozygotes Due to a Combined Effect of Hyperinsulinemia and an SstI Polymorphism
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2722 - 2729.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Wang, K. Nakajima, E. T. Leary, G. R. Warnick, J. S. Cohn, P. N. Hopkins, L. L. Wu, D. D. Cilla, J. Zhong, and R. J. Havel
Ratio of Remnant-like Particle-Cholesterol to Serum Total Triglycerides Is an Effective Alternative to Ultracentrifugal and Electrophoretic Methods in the Diagnosis of Familial Type III Hyperlipoproteinemia
Clin. Chem., November 1, 1999; 45(11): 1981 - 1987.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. Mero, L. Suurinkeroinen, M. Syvänne, P. Knudsen, H. Yki-Järvinen, and M.-R. Taskinen
Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
J. Lipid Res., September 1, 1999; 40(9): 1663 - 1670.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
C. Jonker, B. Schmand, J. Lindeboom, L. M. Havekes, and L. J. Launer
Association Between Apolipoprotein E{epsilon}4 and the Rate of Cognitive Decline in Community-Dwelling Elderly Individuals With and Without Dementia
Arch Neurol, August 1, 1998; 55(8): 1065 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. Mero, A. Van Tol, L. M. Scheek, T. Van Gent, C. Labeur, M. Rosseneu, and M-R. Taskinen
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities
J. Lipid Res., July 1, 1998; 39(7): 1493 - 1502.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Mero, M. Syvanne, B. Eliasson, U. Smith, and M.-R. Taskinen
Postprandial Elevation of ApoB-48-Containing Triglyceride-Rich Particles and Retinyl Esters in Normolipemic Males Who Smoke
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2096 - 2102.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. A. Boer, C. Ehnholm, H.-J. Menzel, L. M. Havekes, M. Rosseneu, D. S. J. O'Reilly, L. Tiret, and f. t. E. Group
Interactions Between Lifestyle-Related Factors and the ApoE Polymorphism on Plasma Lipids and Apolipoproteins : The EARS Study
Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1675 - 1681.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Malmstrom, C. J. Packard, T. D. G. Watson, S. Rannikko, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M.-R. Taskinen
Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men
Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1454 - 1464.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.-F. Hau, A. H.M. Smelt, A. J.G.H. Bindels, E. J.G. Sijbrands, A. Van der Laarse, W. Onkenhout, W. van Duyvenvoorde, and H. M.G. Princen
Effects of Fish Oil on Oxidation Resistance of VLDL in Hypertriglyceridemic Patients
Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1197 - 1202.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Gaw, C. J. Packard, G. M. Lindsay, E. F. Murray, B. A. Griffin, M. J. Caslake, I. Colquhoun, D. J. Wheatley, A. R. Lorimer, and J. Shepherd
Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism
Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 236 - 249.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Syvanne, J. Kahri, K. S. Virtanen, and M.-R. Taskinen
HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus
Circulation, August 1, 1995; 92(3): 364 - 370.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Gylling, K. Kontula, and T. A. Miettinen
Cholesterol Absorption and Metabolism and LDL Kinetics in Healthy Men With Different Apoprotein E Phenotypes and Apoprotein B Xba I and LDL Receptor Pvu II Genotypes
Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 208 - 213.
[Abstract] [Full Text]


Home page
CirculationHome page
J. H. Stengard, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing
Apolipoprotein E Polymorphism Predicts Death From Coronary Heart Disease in a Longitudinal Study of Elderly Finnish Men
Circulation, January 15, 1995; 91(2): 265 - 269.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1987 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement